Protara Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.99-0.91-1.41-2.45
Price/Sales ratio
1.370.960.740.41
Earnings per Share (EPS)
$-3.07$-3.33$-2.15$-1.24

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-9.53-11.94-1.10-1.09-9.13-0.07-5.22-1.60-0.46-0.52-0.50-9.13
Price/Sales ratio
10.81N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
0.384.020.810.9411.370.160.870.460.290.310.320.16
Price/Cash Flow ratio
-3.19-14.53-1.32-1.46-10.00-0.06-7.48-2.19-1.14-0.56-1.25-10.00
Price/Free Cash Flow ratio
-3.17-14.37-1.31-1.46-9.95-0.06-7.20-2.16-1.13-0.56-1.25-9.95
Price/Earnings Growth ratio
N/A-0.62-0.03-1.570.10-0.000.050.17-0.010.01-0.04-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
-257.12%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
-113.36%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
-113.36%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-152.45%1.69%-1.30%-2.19%-21.03%1.74%1.37%0.24%1.72%N/AN/A-21.03%
Return on Assets
-3.94%-31.65%-65.54%-68.13%-108.14%-211.18%-16.49%-27.30%-57.21%-51.19%-58.21%-108.14%
Return On Equity
-4.05%-33.71%-74.20%-86.25%-124.42%-230.44%-16.81%-29.11%-63.49%-59.16%-48.94%-124.42%
Return on Capital Employed
-9.19%-32.91%-74.67%-87.40%-127.57%-238.64%-17.20%-28.21%-62.35%-59.90%-62.35%-127.57%
Liquidity Ratios
Current Ratio
36.1816.118.414.707.5411.9658.12N/AN/AN/A15.007.54
Quick Ratio
36.1816.118.414.707.5411.9658.1221.3814.8011.1714.697.54
Cash ratio
29.449.687.162.296.2910.6057.838.314.206.434.2010.60
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A380.011.71KN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/A19.881.39K16.33K1.70K298.382.34K2.60KN/A16.33K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/A0.00N/AN/A0.000.000.000.010.09N/A
Debt Equity Ratio
N/AN/AN/A0.00N/AN/A0.000.000.000.010.10N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.05N/A
Total Debt to Capitalization
N/AN/AN/A0.00N/AN/A0.000.000.000.010.05N/A
Interest Coverage Ratio
-8.84-144.93-148.73-117.22N/AN/AN/AN/AN/AN/A-98.04N/A
Cash Flow to Debt Ratio
N/AN/AN/A-1.11KN/AN/A-265.98-40.35-28.85-38.20-4.14N/A
Company Equity Multiplier
1.021.061.131.261.151.091.011.061.101.151.101.10
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-3.38N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.001.011.011.001.001.001.031.011.001.001.001.00
Cash Flow Coverage Ratio
N/AN/AN/A-1.11KN/AN/A-265.98-40.35-28.85-38.20-4.14N/A
Short Term Coverage Ratio
N/AN/AN/A-1.11KN/AN/A-265.98-40.35-28.85-38.20-28.85N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A